Intelligence Profile
Research Papers
The available research on GHK-Cu spans several areas, with recent studies examining its potential applications in wound healing, aging, and tissue regeneration. However, the evidence base is still developing across multiple research areas.
Wound Healing and Tissue Repair
A 2026 study published in Materials Today Bio investigated GHK-Cu's role in glucose regulation and reversing hypoxia in infected diabetic wounds, focusing on cascade catalysis mechanisms. Another study in Bioactive Materials examined injectable hydrogels containing GHK-Cu for treating radiation-induced skin injuries, specifically targeting antioxidant effects and tissue regeneration.
Aging and Longevity Research
Two animal studies explored GHK-Cu's effects on aging processes. A study in Biogerontology used the nematode Caenorhabditis elegans to examine how GHK-Cu might delay aging through mitochondrial function regulation and activation of specific cellular pathways (DAF-16/SKN-1). A separate study published in Research Square investigated behavioral and hippocampal aging effects in middle-aged mice treated with GHK-Cu via different administration routes (intraperitoneal or intranasal), though sample sizes were not specified in the available abstracts.
Bone and Vascular Research
Research published in Biomaterials Advances examined GHK-Cu in the context of bone formation and blood vessel development, specifically studying "osteogenic-angiogenic coupling responses" using specialized microsphere delivery systems.
Review Literature
Two review papers from 2026 discussed GHK-Cu within broader therapeutic peptide contexts - one in International Journal of Molecular Sciences covering aesthetic, metabolic, and endocrine applications, and another in Frontiers in Aging focusing on healthy aging mechanisms.
Analytical Applications
A study in Biosensors explored GHK-Cu's potential as a sensing tool for detecting phenolic compounds, investigating its enzyme-like properties.
Clinical Trials
Limited clinical trial data is currently available for GHK-Cu. One Phase 2 trial (NCT07437586) is actively recruiting participants to study topical GHK-Cu gel for acute skin wound healing, though enrollment numbers and study duration were not specified.
A completed Phase 4 trial (NCT05932732) examined facial treatments including GHK-Cu components, focusing on skin quality, hydration, and barrier function, though this appears to be part of a broader cosmetic treatment evaluation rather than a dedicated GHK-Cu study.
Important Note: The research evidence for GHK-Cu remains preliminary, with most studies conducted in laboratory settings or animal models. More robust human clinical trials are needed to establish safety and efficacy profiles for specific medical applications.